MDT vs SYK
Medtronic and Stryker Corporation, both Healthcare
Stryker Corporation is the larger company at $118B against $102B. On trailing earnings MDT is the cheaper of the two at a P/E of 24.6 against 34.2, a gap that is only a bargain if the two are growing at similar rates. Over the past year MDT returned +5.4% against -11% for SYK. Ryufin's sector-relative Smart Score puts MDT ahead, 8/10 against 7/10.
| Figure | MDT | SYK |
|---|---|---|
| Last close | $92.01 | $330 |
| Market cap | $102B | $118B |
| Trailing P/Elower is cheaper for the same earnings, not automatically better | 24.6 | 34.2 |
| Dividend yield | 3.1% | n/a |
| 1-year return | +5.4% | -11% |
| 5-year return | -19% | +28% |
| Ryufin Smart Scoresector-relative, 1–10 | 8/10 | 7/10 |
Figures from SEC filings and end-of-day closes. Highlighting marks the higher or lower number, which is not the same as the better investment, a low P/E can be a warning and a high one can be deserved.
Medtronic
Revenue of $9.8B in Q4 2026, net income $1.2B. Its largest reported line is Total Other Countries Excluding Ireland, 100% of the disclosed total.
Stryker Corporation
Revenue of $6.6B in Q2 2026, net income $1.3B. Its largest reported line is Instruments, 15% of the disclosed total.
Open these two in the interactive comparison to add more names, change the period or read the correlation.